Covariate Model Selection Approaches for Population Pharmacokinetics: A Systematic Review of Existing Methods, From SCM to AI
Open Access
- 20 January 2025
- journal article
- research article
- Published by Wiley in CPT: Pharmacometrics & Systems Pharmacology
- Vol. 14 (4) , 621-639
Abstract
A growing number of covariate modeling methods have been proposed in the field of popPK modeling, but limited information exists on how they all compare. The objective of this study was to perform a systematic review of all popPK covariate modeling methods, focusing on assessing the existing knowledge on their performances. For each method of each article included in this review, evaluation setting, performance metrics along with their associated values, and relative computational times were reported when available. Evaluation settings report was done for uncertainty assessment of communicated results. Results showed that EBEs‐based ML methods stood out as the best covariate selection methods. AALASSO, a hybrid genetic algorithm, FREM with a clinical significance criterion and SCM+ with stagewise filtering were the best covariate model selection techniques—AALASSO being the very best one. Results also showed a lack of consensus on how to benchmark simulated datasets of different scenarios when evaluating method performances, but also on which metrics to use for method evaluation. We propose to systematically report TPR (sensitivity), FPR (Type I error), FNR (Type II error), TNR (specificity), covariate parameter error bias (MPE) and precision (RMSE), clinical relevance, and model fitness by means of BIC, concentration prediction error bias (MPE), and precision (RMSE) of new proposed methods and compare them with SCM. We propose to systematically combine covariate selection techniques to SCM or FFEM to allow for comparison with SCM. We also highlight the need for an open‐source benchmark of simulated datasets on a representative set of scenarios.Keywords
This publication has 37 references indexed in Scilit:
- Development of a genetic algorithm and NONMEM workbench for automating and improving population pharmacokinetic/pharmacodynamic model selectionJournal of Pharmacokinetics and Pharmacodynamics, 2021
- Fast screening of covariates in population models empowered by machine learningJournal of Pharmacokinetics and Pharmacodynamics, 2021
- Operating characteristics of stepwise covariate selection in pharmacometric modelingJournal of Pharmacokinetics and Pharmacodynamics, 2019
- Adjusted adaptive Lasso for covariate model-building in nonlinear mixed-effect pharmacokinetic modelsJournal of Pharmacokinetics and Pharmacodynamics, 2017
- Application of a single-objective, hybrid genetic algorithm approach to pharmacokinetic model buildingJournal of Pharmacokinetics and Pharmacodynamics, 2012
- The lasso—a novel method for predictive covariate model building in nonlinear mixed effects modelsJournal of Pharmacokinetics and Pharmacodynamics, 2007
- Modelling the influence of MDR1 polymorphism on digoxin pharmacokinetic parametersEuropean Journal of Clinical Pharmacology, 2007
- A Genetic Algorithm-Based, Hybrid Machine Learning Approach to Model SelectionJournal of Pharmacokinetics and Pharmacodynamics, 2006
- Cluster Analysis: An Alternative Method for Covariate Selection in population Pharmacokinetic ModelingJournal of Pharmacokinetics and Pharmacodynamics, 2005
- Building population pharmacokineticpharmacodynamic models. I. Models for covariate effectsJournal of Pharmacokinetics and Biopharmaceutics, 1992